Mechanisms of carcinogenesis and the mutant mouse

B O Williams1, T Jacks

  • 1Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139, USA. bowillia@athena.mit.edu

Insights

Researchers created new mouse models with mutations in tumor suppressor genes to study cancer. These models, including ApcMin and p53 mutants, help investigate carcinogenesis mechanisms.

Area of Science:

  • Genetics and Molecular Biology
  • Cancer Research
  • Developmental Biology

Background:

  • Gene targeting in embryonic stem cells enables the creation of novel mouse models.
  • These models carry mutations in genes homologous to human tumor suppressor genes.
  • Studying these mutations provides insights into cancer development.

Purpose of the Study:

  • To review the phenotypes of newly created mouse strains with tumor suppressor gene mutations.
  • To discuss recent experiments using specific mutant mouse models (ApcMin and p53).
  • To explore the mechanisms of carcinogenesis.

Main Methods:

  • Gene targeting in embryonic stem cells.
  • Generation of mouse strains with specific gene mutations.
  • Phenotypic analysis of mutant mice.
  • Experimental studies on carcinogenesis mechanisms.

Main Results:

  • Development of multiple mouse strains with mutations in tumor suppressor gene homologs.
  • Detailed review of the observed phenotypes in these mutant strains.
  • Discussion of experimental findings from ApcMin and p53 mutant animals.

Conclusions:

  • Mutant mouse models are valuable tools for studying tumor suppressor gene function.
  • These models facilitate the investigation of specific molecular mechanisms underlying cancer.
  • Further research using these models can advance our understanding of carcinogenesis.

Related Concept Videos

Mutations01:39

Mutations

Overview
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...